Viewing Study NCT00330434



Ignite Creation Date: 2024-05-05 @ 4:54 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00330434
Status: WITHDRAWN
Last Update Posted: 2020-11-10
First Post: 2006-05-25

Brief Title: Effect of Ethanol and Genetic Polymorphisms on Bupropion Metabolism
Sponsor: Tufts University
Organization: Tufts University

Study Overview

Official Title: Human CYP2B6 Induction by Ethanol and Polymorphisms
Status: WITHDRAWN
Status Verified Date: 2020-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Study was a F32 Fellowship Trial was proposed however Principle Investigator does not believe trial took place
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The two purposes of this study are

1 to determine what effect the chronic and moderateheavy drinking of alcoholic beverages has

1 on the blood level of bupropion and chlorzoxazone and their major breakdown products in the blood and
2 on the stimulant effect of bupropion and
2 to determine what effect a normal and common 25 frequency genetic variation of a specific liver enzyme that breaks down bupropion has

1 on the blood levels of bupropion and its major breakdown products in the blood and
2 on the stimulant effect of bupropion

Two groups of volunteers will be recruited for this study

1 volunteers who drink moderate to heavy amounts of alcohol frequently and
2 volunteers who usually do not drink alcohol

Volunteers will NOT be asked to change their drinking or nondrinking habits during the study
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
1F32AA015647-01A1 NIH None httpsreporternihgovquickSearch1F32AA015647-01A1
F32AA015647-01A1 NIH None None